Showing results (91-100 of 436) with videos related to

Sort By:
Pageof 44
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2017
Biomarker-Stratified Phase III Clinical Trials: Enhancement with a Subgroup-Focused Sequential DesignShigeyuki Matsui, John Crowley
Blood|May 22, 2008
Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalitiesBart Barlogie, Mauricio Pineda-Roman, Frits van Rhee, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 13, 2010
Recurrent spontaneous gastrointestinal graft-versus-host disease in autologous hematopoietic stem cell transplantationSomashekar G Krishna, Bart Barlogie, Laura W Lamps, et al.
Seminars in Oncology|April 30, 2003
Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: an update of a US intergroup trial (SW0G S9003)Madhav V Dhodapkar, Joth L Jacobson, Morie A Gertz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 18, 2011
Earlier response assessment in invasive aspergillosis based on the kinetics of serum Aspergillus galactomannan: proposal for a new definitionSimone A Nouér, Marcio Nucci, Naveen Sanath Kumar, et al.
Radiology|March 3, 2004
Multiple myeloma: clinical review and diagnostic imagingEdgardo J C Angtuaco, Athanasios B T Fassas, Ronald Walker, et al.
American Journal of Surgery|July 27, 2011
The surgical management of abdominal pain in the multiple myeloma patientJared Garrett, V Suzanne Klimberg, Elias Anaissie, et al.
Blood|March 10, 2005
Cyclin D dysregulation: an early and unifying pathogenic event in multiple myelomaP Leif Bergsagel, W Michael Kuehl, Fenghuang Zhan, et al.
Investigational New Drugs|May 11, 2002
The evaluation of gemcitabine in resistant or relapsing multiple myeloma, phase II: a Southwest Oncology Group studyJames K Weick, John J Crowley, Mohamed A Hussein, et al.
Hematology. American Society of Hematology. Education Program|November 26, 2002
Multiple myelomaKenneth C Anderson, John D Shaughnessy, Bart Barlogie, et al.
Pageof 44